Skip to main content
Top
Published in: Urolithiasis 6/2018

01-11-2018 | Original Paper

Three-dimensional evaluation of perirenal fat volume in patients with nephrolithiasis

Authors: Daniel J. Lama, Shoaib Safiullah, Albert Yang, Zhamshid Okhunov, Jaime Landman, Ralph V. Clayman

Published in: Urolithiasis | Issue 6/2018

Login to get access

Abstract

The concept of adipose tissue as an organ unto itself represents a new medical construct; already differences in the volume of perirenal fat around a tumor-bearing kidney have been described. We hypothesized that renal calculi may have similar impact on perirenal fat or alternatively abnormalities in urinary metabolites may be the result of perirenal fat affecting renal metabolism and subsequent stone formation. Accordingly, we conducted a study utilizing three-dimensional imaging software to evaluate perirenal fat volume (PFV) in patients with nephrolithiasis. Among 40 patients with a history of unilateral nephrolithiasis who underwent percutaneous nephrolithotomy between 2010 and 2016, the following data were acquired: body mass index, past medical history, stone characteristics and composition (i.e., calcium oxalate, calcium phosphate, uric acid, and struvite calculi). In addition, patients were stratified by dominant stone composition (≥ 50% fraction). Bilateral PFV measurements were obtained using the preoperative computed tomography scan and specialized three-dimensional imaging software. The PFV of stone-bearing kidneys was significantly greater than non-stone-bearing kidneys (397.3 and 323 cc, respectively; p = 0.004), with the PFV difference in patients with CO-dominant stone-bearing kidneys reaching statistical significance (p = 0.003). Subgroup analysis showed greater PFV surrounding the stone-bearing kidney irrespective of gender (p = 0.03), with male patients possessing significantly greater stone-bearing (p = 0.01) and bilateral PFV (p = 0.01) compared to females. No significant correlations were found between PFV and stone volume or stone density. The PFV of calcium oxalate stone-bearing kidneys is significantly greater than non-stone-bearing kidneys for both male and female patients with nephrolithiasis.
Literature
1.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462CrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462CrossRef
2.
go back to reference Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8 Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8
3.
go back to reference Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRef Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRef
4.
go back to reference Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244–2248CrossRef Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244–2248CrossRef
5.
go back to reference Tran TY, Flynn M, O’Bell J, Pareek G (2016) Calculated insulin resistance correlates with stone-forming urinary metabolic changes and greater stone burden in high-risk stone patients. Clin Nephrol 85:316–320CrossRef Tran TY, Flynn M, O’Bell J, Pareek G (2016) Calculated insulin resistance correlates with stone-forming urinary metabolic changes and greater stone burden in high-risk stone patients. Clin Nephrol 85:316–320CrossRef
6.
go back to reference DiBianco JM, Jarrett TW, Mufarrij P (2015) Metabolic syndrome and nephrolithiasis risk: should the medical management of nephrolithiasis include the treatment of metabolic syndrome? Rev Urol 17:117–128PubMedPubMedCentral DiBianco JM, Jarrett TW, Mufarrij P (2015) Metabolic syndrome and nephrolithiasis risk: should the medical management of nephrolithiasis include the treatment of metabolic syndrome? Rev Urol 17:117–128PubMedPubMedCentral
7.
go back to reference Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30:246–253CrossRef Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30:246–253CrossRef
8.
go back to reference Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed
9.
go back to reference Fox CS, Larson MG, Leip EP, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850CrossRef Fox CS, Larson MG, Leip EP, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850CrossRef
10.
go back to reference von Hafe P, Pina F, Perez A, Tavares M, Barros H (2004) Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 12:1930–1935CrossRef von Hafe P, Pina F, Perez A, Tavares M, Barros H (2004) Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 12:1930–1935CrossRef
11.
go back to reference Okhunov Z, Mues AC, Kline M, Haramis G, Xu B, Mirabile G, Vira M, Landman J (2012) Evaluation of perirenal fat as a predictor of cT1a renal cortical neoplasm histopathology and surgical outcomes. J Endourol 26:911–916CrossRef Okhunov Z, Mues AC, Kline M, Haramis G, Xu B, Mirabile G, Vira M, Landman J (2012) Evaluation of perirenal fat as a predictor of cT1a renal cortical neoplasm histopathology and surgical outcomes. J Endourol 26:911–916CrossRef
13.
go back to reference Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134–2140CrossRef Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134–2140CrossRef
14.
go back to reference Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG (2010) Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906CrossRef Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG (2010) Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906CrossRef
15.
go back to reference Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790CrossRef Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790CrossRef
16.
go back to reference Stolarczyk J, Carone FA (1975) Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol 78:285–296PubMedPubMedCentral Stolarczyk J, Carone FA (1975) Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol 78:285–296PubMedPubMedCentral
17.
go back to reference Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28:S58-65CrossRef Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28:S58-65CrossRef
18.
go back to reference Ma S, Zhu XY, Eirin A, Woollard JR, Jordan KL, Tang H, Lerman A, Lerman LO (2016) Perirenal fat promotes renal arterial endothelial dysfunction in obese swine through tumor necrosis factor-alpha. J Urol 195:1152–1159CrossRef Ma S, Zhu XY, Eirin A, Woollard JR, Jordan KL, Tang H, Lerman A, Lerman LO (2016) Perirenal fat promotes renal arterial endothelial dysfunction in obese swine through tumor necrosis factor-alpha. J Urol 195:1152–1159CrossRef
19.
go back to reference Hou N, Han F, Wang M, Huang N, Zhao J, Liu X, Sun X (2014) Perirenal fat associated with microalbuminuria in obese rats. Int Urol Nephrol 46:839–845CrossRef Hou N, Han F, Wang M, Huang N, Zhao J, Liu X, Sun X (2014) Perirenal fat associated with microalbuminuria in obese rats. Int Urol Nephrol 46:839–845CrossRef
20.
go back to reference Pragasam V, Sakthivel R, Kalaiselvi P, Rajesh NG, Varalakshmi P (2005) Detection of endothelial nitric oxide synthase and NADPH-diaphorase in experimentally induced hyperoxaluric animals. Urol Res 33:301–308CrossRef Pragasam V, Sakthivel R, Kalaiselvi P, Rajesh NG, Varalakshmi P (2005) Detection of endothelial nitric oxide synthase and NADPH-diaphorase in experimentally induced hyperoxaluric animals. Urol Res 33:301–308CrossRef
21.
go back to reference Bagga HS, Chi T, Miller J, Stoller ML (2013) New insights into the pathogenesis of renal calculi. Urol Clin North Am 40:1–12CrossRef Bagga HS, Chi T, Miller J, Stoller ML (2013) New insights into the pathogenesis of renal calculi. Urol Clin North Am 40:1–12CrossRef
22.
go back to reference Jang S, Lee CH, Choi KM, Lee J, Choi JW, Kim KA, Park CM (2011) Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol 17:3335–3341CrossRef Jang S, Lee CH, Choi KM, Lee J, Choi JW, Kim KA, Park CM (2011) Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol 17:3335–3341CrossRef
23.
go back to reference Shuster A, Patlas M, Pinthus JH, Mourtzakis M (2012) The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 85:1–10CrossRef Shuster A, Patlas M, Pinthus JH, Mourtzakis M (2012) The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 85:1–10CrossRef
24.
go back to reference Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Varsan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr., Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRef Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Varsan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr., Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRef
25.
go back to reference Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR (2007) A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity 15:994–1003CrossRef Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR (2007) A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity 15:994–1003CrossRef
26.
go back to reference Favre G, Grangeon-Chapon C, Raffaelli C, Francois-Chalmin F, Ianelli A, Esnault V (2017) Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. PLoS One 12:e0175561CrossRef Favre G, Grangeon-Chapon C, Raffaelli C, Francois-Chalmin F, Ianelli A, Esnault V (2017) Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. PLoS One 12:e0175561CrossRef
27.
go back to reference Grauer WO, Moss AA, Cann CE, Goldberg HI (1984) Quantification of body fat distribution in the abdomen using computed tomography. Am J Clin Nutr 39:631–637CrossRef Grauer WO, Moss AA, Cann CE, Goldberg HI (1984) Quantification of body fat distribution in the abdomen using computed tomography. Am J Clin Nutr 39:631–637CrossRef
29.
go back to reference Baba S, Jacene HA, Engles JM, Hond H, Wahl RL (2010) CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med 51:246–250CrossRef Baba S, Jacene HA, Engles JM, Hond H, Wahl RL (2010) CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med 51:246–250CrossRef
30.
go back to reference Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMed Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMed
Metadata
Title
Three-dimensional evaluation of perirenal fat volume in patients with nephrolithiasis
Authors
Daniel J. Lama
Shoaib Safiullah
Albert Yang
Zhamshid Okhunov
Jaime Landman
Ralph V. Clayman
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 6/2018
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1047-9

Other articles of this Issue 6/2018

Urolithiasis 6/2018 Go to the issue